147 Participants NeededMy employer runs this trial

Amniotic Membrane Product for Foot and Leg Ulcers

(CAMPR-II Trial)

Recruiting at 6 trial locations
MD
Overseen ByMarissa Docter, RN, BSN, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Capsicure, LLC
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

CAMPR-II Trial: A multicenter hybrid platform trial comparing the effects of a prospective cohort treated with a saline-hydrated allogeneic dual-layer amniotic membrane product or a synthetic, resorbable polymeric wound matrix to a coarsened exact matched retrospective control cohort of patients with hard-to-heal DFUs and VLUs

Who Is on the Research Team?

WC

Windy Cole, DPM

Principal Investigator

Capsicure, LLC

Are You a Good Fit for This Trial?

This trial is for people with hard-to-heal diabetic foot ulcers (DFUs) or venous leg ulcers (VLUs). Participants should have chronic wounds that haven't responded well to standard treatments. Specific inclusion and exclusion criteria are not detailed here.

Inclusion Criteria

If I have more than one wound, the largest one will be chosen for the study.
I am not pregnant or breastfeeding and will use effective birth control during the study.
My wound has not healed much in the past 4 weeks.
See 6 more

Exclusion Criteria

Pregnancy
Lactation
Inability to adhere to the study protocol or study visit schedule
See 6 more

What Are the Treatments Tested in This Trial?

Interventions

  • Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product
  • Synthetic, Resorbable Polymeric Wound Matrix

Trial Overview

The study compares two advanced wound dressings—a saline-hydrated amniotic membrane wrap and a synthetic, dissolvable wound matrix—against past patient data. The goal is to see which helps heal stubborn foot and leg ulcers better.

How Is the Trial Designed?

3

Treatment groups

Experimental Treatment

Active Control

Group I: IP2: Microlyte®Experimental Treatment1 Intervention
Group II: IP1: Membrane Wrap - HydroExperimental Treatment1 Intervention
Group III: Standard of CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Capsicure, LLC

Lead Sponsor

Trials
2
Recruited
300+

BioLab Holdings

Industry Sponsor

Trials
1
Recruited
380+